Reported results
- Total TTR net product revenues were $1,149,959 thousand, representing 59% growth compared to Q3 2025.
- Total Rare net product revenues were $141,987 thousand, representing 12% growth compared to Q3 2025.
- GAAP Net income was $2,167,335 thousand for the third quarter of 2026.
- Non-GAAP Net income was $2,241,910 thousand for the third quarter of 2026.
- GAAP Income from operations was $345,798 thousand, while Non-GAAP Income from operations was $424,916 thousand.
Guidance
- Total TTR net product revenues: $4,200 million - $4,500 million
- Total Rare net product revenues: $500 million - $600 million
- Total net product revenues: $4,700 million - $5,100 million
- Net revenues from collaborations and royalties: $575 million - $625 million
- Non-GAAP R&D and SG&A expenses: $2,700 million - $2,800 million
Notes
During the three months ended September 30, 2026, the company recorded a benefit from income taxes of $1.9 billion, primarily related to the release of valuation allowances on certain U.S. federal and state deferred tax assets.
Price and volatility reaction
The stock moved -25.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +69.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 232.4 | 2026-10-28 |
| Close after release | 174 | 2026-10-29 |
| Realised move | -25.1% | close to close |
| 30d ATM IV change | +69.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.
